{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2021", "item": "https://www.patentleaderboard.com/2021/"}, {"@type": "ListItem", "position": 3, "name": "Johnson & Johnson", "item": "https://www.patentleaderboard.com/2021/company/jnj"}, {"@type": "ListItem", "position": 4, "name": "Jonathan Langdown", "item": "https://www.patentleaderboard.com/2021/inventor/fl:jo_ln:langdown-1"}]}

Home › 2021 › Johnson & Johnson › Jonathan Langdown

Jonathan Langdown — 1 Patent in 2021

Johnson & Johnson: 1 patents #487 of 1,204Top 45%

Cambridge, GB: #256 of 831 inventorsTop 35%

Overall (2021): #396,326 of 548,734Top 75%

1 Patents 2021

Issued Patents 2021

Showing 1–1 of 1 patents

Patent #	Title	Co-Inventors	Date	Approx Value ⓘ
11155637	Thrombin-binding antibody molecules and uses thereof	James Andrew Huntington, Trevor Baglin	2021-10-26	$230,543,000

Jonathan Langdown — 1 Patent in 2021

Issued Patents 2021

Patent Widget